BİŞGİN, A. Et Al. 2012. Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients. Molecular Immunology Immunogenetics Congress , (Turkey).

BİŞGİN, A., YALÇIN, A. D., & Gorczynski, R., (2012). Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients . Molecular Immunology Immunogenetics Congress, Turkey

BİŞGİN, ATIL, ARZU DİDEM YALÇIN, And Reginald Gorczynski. "Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients," Molecular Immunology Immunogenetics Congress, Turkey, 2012

BİŞGİN, ATIL Et Al. "Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients." Molecular Immunology Immunogenetics Congress , Turkey, 2012

BİŞGİN, A. YALÇIN, A. D. And Gorczynski, R. (2012) . "Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients." Molecular Immunology Immunogenetics Congress , Turkey.

@conferencepaper{conferencepaper, author={ATIL BİŞGİN Et Al. }, title={Circulating soluble tumor necrosis related apoptosis inducing ligand TRAIL is decreased in type 2 newly diagnosed non drug using diabetic patients}, congress name={Molecular Immunology Immunogenetics Congress}, city={}, country={Turkey}, year={2012}}